PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.63%
Revenue growth under 50% of TOST's 19.41%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
6.06%
Gross profit growth under 50% of TOST's 19.54%. Michael Burry would be concerned about a severe competitive disadvantage.
4.87%
EBIT growth below 50% of TOST's 13.04%. Michael Burry would suspect deeper competitive or cost structure issues.
4.87%
Operating income growth under 50% of TOST's 13.04%. Michael Burry would be concerned about deeper cost or sales issues.
9.45%
Positive net income growth while TOST is negative. John Neff might see a big relative performance advantage.
7.14%
Positive EPS growth while TOST is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
7.14%
Positive diluted EPS growth while TOST is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.88%
Share count expansion well above TOST's 0.98%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.88%
Diluted share count expanding well above TOST's 0.98%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
24.20%
OCF growth under 50% of TOST's 190.91%. Michael Burry might suspect questionable revenue recognition or rising costs.
27.27%
FCF growth under 50% of TOST's 160.00%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-26.87%
Negative 10Y revenue/share CAGR while TOST stands at 152.80%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-26.87%
Negative 5Y CAGR while TOST stands at 152.80%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-26.87%
Negative 3Y CAGR while TOST stands at 152.80%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
60.31%
10Y OCF/share CAGR under 50% of TOST's 138.37%. Michael Burry would worry about a persistent underperformance in cash creation.
60.31%
Below 50% of TOST's 138.37%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
60.31%
3Y OCF/share CAGR under 50% of TOST's 138.37%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
1.38%
Below 50% of TOST's 31.54%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1.38%
Below 50% of TOST's 31.54%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
1.38%
Below 50% of TOST's 31.54%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.79%
Firm’s AR is declining while TOST shows 18.56%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.99%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.03%
Negative asset growth while TOST invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.83%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
2.10%
R&D dropping or stable vs. TOST's 8.24%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
1.53%
SG&A declining or stable vs. TOST's 8.29%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.